BIOSGN — Biosergen AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK17.28m
- SEK15.40m
Annual cashflow statement for Biosergen AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | — | — |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -6.23 | -34.1 | -34.1 | -27.3 |
| Non-Cash Items | -0.498 | -0.24 | 0.081 | 0.229 |
| Other Non-Cash Items | ||||
| Changes in Working Capital | 2.14 | -3.43 | 4.61 | -5.57 |
| Change in Accounts Receivable | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -4.58 | -37.7 | -29.4 | -32.6 |
| Net Issuance / Retirement of Stock | ||||
| Cash from Financing Activities | 0 | 58.8 | 37.1 | 5.14 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -4.58 | 21.1 | 7.68 | -27.5 |